Reclassification of a BRCA2 variant, c.8487G > A (p.Gln2829Gln) located at 3′ end of exon 19, from uncertain significance to likely pathogenic based on splicing alteration: a case report
Japanese Journal of Clinical Oncology · 06.07.2026 · 56 (7) · 899-903
DOI: 10.1093/jjco/hyag047 ↗Kurz gefasst
Fallbericht in der Zeitschrift Japanese Journal of Clinical Oncology, online erschienen am 18.03.2026. Verfasst von Ritsuko Sasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Exons, Breast Neoplasms, BRCA2 Protein, RNA Splicing. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A BRCA2 germline variant, NM_000059.4: c.8487G > A (p.Gln2829Gln), was identified in a Japanese female with multifocal breast cancer and a notable family history of BRCA2-related cancers. While this synonymous variant was reported as a variant of uncertain significance, we suspected its pathogenicity considering its location at the 3′ end of exon 19. This variant is absent in gnomAD and extremely rare in ToMMo jMorp 61KJPN database, with an allelic frequency of 0.000008. All three in silico tools predicted a splicing defect. RT-PCR analysis using total RNA extracted from the patient’s peripheral blood cells demonstrated skipping of entire exon 19, resulting in in-frame deletion. This observation was consistent with a previous report of in vitro minigene assay. The exon 19 encodes 52 amino acids within the single-stranded DNA oligonucleotide/oligosaccharide-binding domain, and thus the in-frame deletion was predicted to impair BRCA2 function. Collectively, we re-classified this variant as likely pathogenic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
- Department of Breast Surgery, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
- Department of Diagnostics and Therapeutics of Intractable Diseases/Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
- Department of Breast Surgery, Kawaguchi Municipal Medical Center, 180 Nishi-araishuku, Kawaguchi, Saitama 333-0833, Japan.
- Department of Medical Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
- Department of Clinical Genetics, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan.
ORCID-Profile: Ritsuko Sasaki, Hidetaka Eguchi, Tomoyuki Aruga
Zitieren
APA
Sasaki, R., Eguchi, H., Yoshioka, S., Nakano, S., Kato, S., Aruga, T., Kutomi, G., & Arai, M. (2026). Reclassification of a BRCA2 variant, c.8487G > A (p.Gln2829Gln) located at 3′ end of exon 19, from uncertain significance to likely pathogenic based on splicing alteration: a case report. Japanese Journal of Clinical Oncology, 56(7), 899-903. https://doi.org/10.1093/jjco/hyag047
Vancouver
Sasaki R, Eguchi H, Yoshioka S, Nakano S, Kato S, Aruga T, et al. Reclassification of a BRCA2 variant, c.8487G > A (p.Gln2829Gln) located at 3′ end of exon 19, from uncertain significance to likely pathogenic based on splicing alteration: a case report. Japanese Journal of Clinical Oncology. 2026;56(7):899-903. doi:10.1093/jjco/hyag047
BibTeX
@article{Sasaki2026,
author = {Sasaki, Ritsuko and Eguchi, Hidetaka and Yoshioka, Sayaka and Nakano, Satoko and Kato, Shunsuke and Aruga, Tomoyuki and Kutomi, Goro and Arai, Masami},
title = {Reclassification of a BRCA2 variant, c.8487G > A (p.Gln2829Gln) located at 3′ end of exon 19, from uncertain significance to likely pathogenic based on splicing alteration: a case report},
journal = {Japanese Journal of Clinical Oncology},
year = {2026},
volume = {56},
number = {7},
pages = {899--903},
doi = {10.1093/jjco/hyag047}
}
EUVIMED